THE LATEST

Read The 2020 Hot Indications List

How can companies determine where to focus as they develop their pipelines and determine new growth opportunities? Kx Advisors’ 2020 Hot Indications List can help. In our 6th annual analysis of global R&D investment, our experts identified the top indications for industry focus.

Download The White Paper

Strategizing for Your First Drug Launch

Kx Advisors’ blog series on Strategizing for your First Drug Launch is intended to support late-stage, pre-revenue pharmaceutical companies who are planning to directly commercialize their first product capitalize on these competitive advantages. Kx’s 3-step approach is designed to help your company build a dynamic commercial strategy tailored to your drug. Please complete the form below to access our analysis.